相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
Tian Zhou et al.
BIOMATERIALS (2018)
Crossing the blood-brain barrier with nanoparticles
Yiqun Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells
Shu Yang et al.
NEUROLOGICAL RESEARCH (2018)
Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
JoEllyn McMillan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Protein bio-corona: critical issue in immune nanotoxicology
Monica Neagu et al.
ARCHIVES OF TOXICOLOGY (2017)
Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
Dongwei Guo et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Laura I. Selby et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
Li Zhang et al.
SCIENTIFIC REPORTS (2017)
Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation
Myosotys Rodriguez et al.
SCIENTIFIC REPORTS (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir
Muneeb Mohideen et al.
BIOMATERIALS (2017)
The Role of HIV Infection in Neurologic Injury
Rossana Scutari et al.
BRAIN SCIENCES (2017)
Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission
Subhra Mandal et al.
AIDS (2017)
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS
Madhavan Nair et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Elvitegravir for the treatment of HIV
Nathan R. Unger et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model
Di Shi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Hans C. Helms et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS
Jingwei Shao et al.
NANOMEDICINE (2016)
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment
Deanna Saylor et al.
NATURE REVIEWS NEUROLOGY (2016)
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method
Narasimha M. Midde et al.
PLOS ONE (2016)
Effect of Polyaryl Hydrocarbons on Cytotoxicity in Monocytic Cells: Potential Role of Cytochromes P450 and Oxidative Stress Pathways
Sabina Ranjit et al.
PLOS ONE (2016)
Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles
Murali M. Yallapu et al.
BIOMATERIALS (2015)
Sustained-release nanoART formulation for the treatment of neuroAIDS
Rahul Dev Jayant et al.
International Journal of Nanomedicine (2015)
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials
Upal Roy et al.
NANOMEDICINE (2015)
Smart nanoparticles as targeting platforms for HIV infections
Rishi Rajat Adhikary et al.
NANOSCALE (2015)
Changes in HIV reservoirs during long-term antiretroviral therapy
Feiyu F. Hong et al.
CURRENT OPINION IN HIV AND AIDS (2015)
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication
Alessandro F. Fois et al.
CURRENT HIV/AIDS REPORTS (2015)
TEER Measurement Techniques for In Vitro Barrier Model Systems
Balaji Srinivasan et al.
JALA (2015)
The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV
Edward R. Hammond et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
Murali M. Yallapu et al.
BIOMATERIALS (2014)
Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Benson J. Edagwa et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Endocytosis and exocytosis of nanoparticles in mammalian cells
Nuri Oh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Towards nanomedicines for neuroAIDS
Vidya Sagar et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages
Dagmar A. Kuhn et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2014)
Monocyte/macrophages and their role in HIV neuropathogenesis
Tricia H. Burdo et al.
IMMUNOLOGICAL REVIEWS (2013)
HIV-associated neurocognitive disorder
David B. Clifford et al.
LANCET INFECTIOUS DISEASES (2013)
Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study
Sudheesh Pilakka-Kanthikeel et al.
PLOS ONE (2013)
Polymeric nanoparticles for drug delivery to the central nervous system
Toral Patel et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
Antiretroviral drug treatment of CNS HIV-1 infection
Aylin Yilmaz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A novel in vitro human microglia model: Characterization of human monocyte-derived microglia
Samar Etemad et al.
JOURNAL OF NEUROSCIENCE METHODS (2012)
Phagocytosis and Endocytosis of Silver Nanoparticles Induce Interleukin-8 Production in Human Macrophages
Seungjae Kim et al.
YONSEI MEDICAL JOURNAL (2012)
Impact of current antiretroviral therapies on neuroAIDS
Pornpun Vivithanaporn et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
Tore-Geir Iversen et al.
NANO TODAY (2011)
Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier
Sneha Avinash Kulkarni et al.
NANOMEDICINE (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Biomaterials/Tissue Interactions: Possible Solutions to Overcome Foreign Body Response
Jacqueline M. Morais et al.
AAPS JOURNAL (2010)
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
Svetlana Gelperina et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Drug-drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition
F. Josephson
JOURNAL OF INTERNAL MEDICINE (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Contribution of CNS Cells in NeuroAlDS
Ashish Swarup Verma et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2010)
Polymeric Nano-Assemblies as Emerging Delivery Carriers for Therapeutic Applications: A Review of Recent Patents
Jianxiang Zhang et al.
RECENT PATENTS ON NANOTECHNOLOGY (2009)
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre et al.
ARCHIVES OF NEUROLOGY (2008)
Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence
Edana Cassol et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies
Y Omidi et al.
BRAIN RESEARCH (2003)
Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
M Maschke et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
分享论文
